Treating venous thromboembolism: enoxaparin.

Abstract

This article reviews the developments that have occurred in the treatment of venous thromboembolism during the last decade, with emphasis on the establishment of low molecular weight heparin as a therapeutic agent of proven efficacy and examines the evidence that supports the movement from inpatient to outpatient hospital management of venous thromboembolism.

• Authors: D J Perry
• Journal: Hospital medicine (London, England : 1998) (Hosp Med) Vol. 62 Issue 12 Pg. 757-64 (Dec 2001) ISSN: 1462-3935 [Print] England
• PMID: 11810736 (Publication Type: Journal Article, Review)

Chemical References

• Anticoagulants
• Enoxaparin

Topics

• Ambulatory Care
• Anticoagulants (therapeutic use)
• Contraindications
• Cost-Benefit Analysis
• Drug Costs
• Enoxaparin (therapeutic use)
• Hospitalization
• Humans
• Obesity (complications)
• Practice Guidelines as Topic
• Pulmonary Embolism (drug therapy)
• Renal Insufficiency (complications)
• Thromboembolism (drug therapy)
• Venous Thrombosis (drug therapy)